US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco Nasdaq Biotechnology ETF

34.52

+0.26900.79%

Volume:3K

Turnover:99.79K

Market Cap:95.96M

PE:- -

High:34.62

Open:34.39

Low:34.37

Close:34.25

52wk High:36.84

52wk Low:23.42

Shares:2.78M

Float Shares:2.78M

Volume Ratio:0.85

T/O Rate:0.10%

Dividend:0.26

Dividend Rate:0.74%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Gilead Exec Says Hiv Market Growth Should Normalize to 2%-3% Within Next Couple of Quarters - Conf Call

THOMSON REUTERS

Amgen Announces Dividend of R$ 0.31 Per Unit, Payable Sept. 17

Press Release: Legend Biotech Appoints Ingrid Zhang as Chief Executive Officer

Vertex Pharmaceuticals partners with Lindsey Vonn for JOURNAVX awareness

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Centene (CNC), Natera (NTRA) and Vertex Pharmaceuticals (VRTX)

After a One-Day Surge Turns Sour: Hua Bao's Pharma ETF and HK Connect Innovative Drug ETF Experience a Pullback, Yet Strong Fundamentals Remain—Data Releases and Outbound Licensing Momentum Continue to Provide Support

Amgen to deploy Veeva Vault CRM globally

Jiangsu Hengrui Secures Green Light for HRS-4139 Tablet Clinical Trials

Sino Biopharmaceutical Stock Slips 1.0% in Hong Kong

Huangjia Ruangan Granules Receives Approval for Phase III Clinical Trial in Chronic Hepatitis B Fibrosis Treatment

Shenyang Xingqi Pharma Gains NMPA Approval to Initiate Clinical Trials for SQ-25012 Injection in Thyroid Eye Disease

港股市场动态：海西新药股价上扬，新药申请获受理推进

Record WCLC Data From Chinese Innovators Signals Clear Recovery for CRO/CDMO Sector, Wall Street Takes Notice

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Amgen Inc. Stock Outperforms Competitors on Strong Trading Day

Amgen’s Phase 3 Dazodalibep Study Nears Data Spotlight for Sjögren’s Investors

CRO Sector Surges Strongly as Multiple Listed Companies Share Latest Business Updates

Roche, GSK's Lung-Cancer Drug Candidates Show Promise in China

FDA Approves Shorter Monitoring Time for Amgen’s Imdelltra First Two Doses

Amgen - Imdelltra Monitoring Reduced to 6-8 Hours for First Two Infusions

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/IBBQ/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IBBQ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","market":"US","secType":"STK","nameCN":"Invesco Nasdaq Biotechnology ETF","latestPrice":34.519,"timestamp":1789568934229,"preClose":34.25,"halted":0,"volume":2899,"delay":0,"changeRate":0.007854014598540097,"floatShares":2780001,"shares":2780001,"eps":0,"marketStatus":"Trading","change":0.269,"latestTime":"09-16 10:33:15 EDT","open":34.39,"high":34.62,"low":34.365,"amount":99792.73214300002,"amplitude":0.007445,"askPrice":34.41,"askSize":1300,"bidPrice":34.37,"bidSize":800,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789588800000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":34.25,"sharesOutstanding":2520001,"nav":34.76286,"aum":96640785.56286,"dividendRate":0.007442,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":34.28,"preClose":34.25,"latestTime":"09:29 EDT","volume":69,"amount":2360.8497660000003,"timestamp":1789565397037,"change":0.03,"changeRate":0.000876,"amplitude":0.008175},"postHourTrading":{"tag":"盘后","latestPrice":34.25,"preClose":34.25,"latestTime":"19:30 EDT","volume":6387,"amount":218773.45,"timestamp":1789515006181,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.852917,"impliedVol":0.1126,"impliedVolPercentile":0.4741},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","floatShares":2780001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.852917,"shares":2780001,"dividePrice":0.2569,"high":34.62,"amplitude":0.007445,"preClose":34.25,"low":34.365,"week52Low":23.42,"pbRate":"--","week52High":36.84,"institutionHeld":0,"latestPrice":34.519,"committee":-0.238095,"eps":0,"divideRate":0.007442,"volume":2899,"delay":0,"ttmEps":0,"open":34.39,"prevYearClose":28.3962,"prevWeekClose":34.472,"prevMonthClose":35.4742,"prevQuarterClose":32.66,"fiveDayClose":34.9277,"twentyDayClose":34.6197,"sixtyDayClose":30.4995},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBBQ\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"IBBQ","amount":0.03422,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"IBBQ","amount":0.03609,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"IBBQ","amount":0.0906,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"IBBQ","amount":0.09576,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"IBBQ","amount":0.0287,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBBQ\",market:\"US\",,,undefined,":[{"executeDate":"2021-09-20","recordDate":"2021-09-21","paymentDate":"2021-09-30","value":0.04324,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-31","value":0.10511,"currency":"USD"},{"executeDate":"2022-03-21","recordDate":"2022-03-22","paymentDate":"2022-03-31","value":0.03778,"currency":"USD"},{"executeDate":"2022-06-21","recordDate":"2022-06-22","paymentDate":"2022-06-30","value":0.04264,"currency":"USD"},{"executeDate":"2022-09-19","recordDate":"2022-09-20","paymentDate":"2022-09-23","value":0.03769,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBBQ\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBBQ\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667462372","title":"Gilead Exec Says Hiv Market Growth Should Normalize to 2%-3% Within Next Couple of Quarters - Conf Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2667462372","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667462372?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:04","pubTimestamp":1789484692,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nFWN4570NU:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0823416689.USD","SG9999015978.USD","LU0859254822.USD","BK4568","IE00B3T34201.USD","LU2324357040.USD","BK4550","LU0289739699.SGD","BMED","LU0114720955.EUR","IBB","IE00B19Z3B42.SGD","LU0882574055.USD","LU0965509010.AUD","IE00BSNM7G36.USD","BK4578","BBH","GILD","MEDI","BIB","IE00B19Z3581.USD","LU0058720904.USD","LU1934455194.USD","IBBQ","BK4139","IE00BZ1G4Q59.USD","LU0965509101.SGD","TMED","LU1061106388.HKD","LU1430594728.SGD","LU0965508806.USD","LU2089984988.USD","LU1037948541.HKD","SG9999015945.SGD","BK4532","LU1023059063.AUD","LU1934455277.USD","LU2357627491.SGD","LU1674673428.USD","LU0889565916.HKD","LU1571399168.USD","LU2112291526.USD","LU0109394709.USD","LU0234570918.USD","LU1934455863.HKD","TBXU","LU1585245621.USD","LU1674673691.USD","LU0122379950.USD","LU1057294990.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667642502","title":"Amgen Announces Dividend of R$ 0.31 Per Unit, Payable Sept. 17","url":"https://stock-news.laohu8.com/highlight/detail?id=2667642502","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667642502?lang=en_us&edition=fundamental","pubTime":"2026-09-15 20:17","pubTimestamp":1789474653,"startTime":"0","endTime":"0","summary":"Amgen announces dividend of R$ 0.31 per unit, payable Sept. 17Amgen declared a Q3 2026 dividend of R$ 0.31 per unit on ISIN BRAMGNBDR004.Shares trade ex-dividend from Aug. 20, 2026; last day with enti","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nNDL9rWH4V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","PBE","LU0109394709.USD","LU1057294990.SGD","LU0122379950.USD","LU2242646821.SGD","LU2089984988.USD","SG9999001440.SGD","LU1983299246.USD","BK4581","IE0009355771.USD","LU1061106388.HKD","IE00B2B36J28.USD","LU0289739699.SGD","IE00BJJMRZ35.SGD","BK4585","LU2242652126.USD","TBXU","LU2112291526.USD","IBB","LU0320765992.SGD","LU1571399168.USD","PJP","IE00BJT1NW94.SGD","BK4139","IE00B4R5TH58.HKD","BK4533","BK4566","BK4599","BK4534","IBBQ","LU2468319806.SGD","LU0868494617.USD","BIB","BBH","AMGN","IE00BFTCPJ56.SGD","IE0002141913.USD","LU1023059063.AUD","BK4588","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667444786","title":"Press Release: Legend Biotech Appoints Ingrid Zhang as Chief Executive Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2667444786","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667444786?lang=en_us&edition=fundamental","pubTime":"2026-09-15 20:00","pubTimestamp":1789473600,"startTime":"0","endTime":"0","summary":"BRIDGEWATER, N.J., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (\"Legend Biotech\" or the \"Company\"), a global leader in cell therapy, today announced that its Board of ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBT","CANC","R","LEGN","GNOM","BK4585","LFSC","XBI","BK4505","TBXU","MEDI","BK4022","SYNB","BK4139","BK4232","MEMS","BK4581","CNCR","BK4588","IBBQ","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667644589","title":"Vertex Pharmaceuticals partners with Lindsey Vonn for JOURNAVX awareness","url":"https://stock-news.laohu8.com/highlight/detail?id=2667644589","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667644589?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:36","pubTimestamp":1789472175,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals (VRTX) has partnered with world champion skier Lindsey Vonn to raise awareness of JOURNAVX, a prescription non-opioid medici...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vertex-pharmaceuticals-partners-with-lindsey-vonn-for-journavx-awareness-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vertex-pharmaceuticals-partners-with-lindsey-vonn-for-journavx-awareness-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0823416689.USD","BBH","IE00BJT1NW94.SGD","BK4533","PBE","LU1674673691.USD","IBBQ","LU2362541273.HKD","BK4567","IDNA","LU2362541513.USD","LU1035775433.USD","IE00B19Z9P08.USD","LU0256863811.USD","LU0757428866.USD","BK4588","SG9999001176.SGD","LU1674673428.USD","LU2456880835.USD","VERX","BK4023","IE0002141913.USD","LU1069344957.HKD","LU1430594728.SGD","IE00B19Z3B42.SGD","LU2468319806.SGD","TBXU","IE00B19Z9Z06.USD","LU2362540622.SGD","SGXZ57979304.SGD","IE00BJJMRZ35.SGD","LU1559883803.SGD","SG9999001176.USD","IE00BFTCPJ56.SGD","BIB","BK4532","BK4585","IBB","LU0061475181.USD","LU1585245621.USD","LU2237438978.USD","LU0566484027.USD","GNMX","LU1093756325.SGD","LU0109394709.USD","IE00B2B36J28.USD","IE0009355771.USD","LU0234570918.USD","VRTX","SG9999013999.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667641173","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Centene (CNC), Natera (NTRA) and Vertex Pharmaceuticals (VRTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667641173","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667641173?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:20","pubTimestamp":1789471221,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Centene (CNC), Natera (NTRA) and Vertex Pharmaceut...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-centene-cnc-natera-ntra-and-vertex-pharmaceuticals-vrtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-centene-cnc-natera-ntra-and-vertex-pharmaceuticals-vrtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","LU0053671581.USD","BK4585","LU1035775433.USD","XLV","NTRA","LU0859254822.USD","CNC","LU0130518102.USD","GNMX","IBBQ","LU1291159041.SGD","HCSG","IE0002270589.USD","LU1988902786.USD","PBE","BK4023","LU0289739699.SGD","CNCG","LU0648000940.SGD","LU0823416689.USD","LU2065171311.SGD","TBXU","VRTX","BK4567","LABU","BK4139","IE0009355771.USD","IE00B19Z3581.USD","LU2236285917.USD","LU2462157665.USD","HELX","VERX","BK4137","LU1430594728.SGD","XBI","BK4581","IBB","IE00B19Z9Z06.USD","BIB","LU0234570918.USD","GNOM","LU1674673691.USD","LU0128526141.USD","BBH","LU0012050646.USD","LU2456880835.USD","LU1585245621.USD","LU2065169927.USD","BK4154"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191166040","title":"After a One-Day Surge Turns Sour: Hua Bao's Pharma ETF and HK Connect Innovative Drug ETF Experience a Pullback, Yet Strong Fundamentals Remain—Data Releases and Outbound Licensing Momentum Continue to Provide Support","url":"https://stock-news.laohu8.com/highlight/detail?id=1191166040","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191166040?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:10","pubTimestamp":1789470640,"startTime":"0","endTime":"0","summary":"Following a sharp rally against the broader market, A-share and Hong Kong-listed innovative drug stocks faced a short-term correction on September 15. The underlying indices of Hua Bao's Pharma ETF...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FDN","06978","LNGR","159316","BK1574","159992","BK4585","MEDX","BK1161","FLHK","BK4588","BK4550","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667641127","title":"Amgen to deploy Veeva Vault CRM globally","url":"https://stock-news.laohu8.com/highlight/detail?id=2667641127","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667641127?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:10","pubTimestamp":1789470620,"startTime":"0","endTime":"0","summary":"Veeva Systems (VEEV) announced that Amgen (AMGN) plans to deploy Veeva Vault CRM globally, building on a collaboration spanning more than a decade....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amgen-to-deploy-veeva-vault-crm-globally-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amgen-to-deploy-veeva-vault-crm-globally-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4534","LU2468319806.SGD","BK4504","BIB","BK4588","LU2089984988.USD","BK4599","LU0122379950.USD","LU0006306889.USD","BK4585","BK4566","LU2242652126.USD","IBBQ","04332","AMGN","IE0009355771.USD","BK4167","PBE","SG9999001440.SGD","LU0106261372.USD","LU0170899867.USD","LU1983299246.USD","BK4533","LU0109394709.USD","LU2112291526.USD","LU0320765992.SGD","LGHT","IE00B4R5TH58.HKD","IBB","LU1989764664.SGD","IE00B2B36J28.USD","LU1989764748.USD","LU0868494617.USD","LU1057294990.SGD","LU0058720904.USD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","TBXU","LU0266013472.USD","LU1061106388.HKD","IE00BFTCPJ56.SGD","LU0289739699.SGD","BK4139","BK4613","VEEV","LU0889565916.HKD","LU1023059063.AUD","LU1571399168.USD","IE0002141913.USD","BK4528","BBH","PJP","LU2242646821.SGD","EKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151952155","title":"Jiangsu Hengrui Secures Green Light for HRS-4139 Tablet Clinical Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=1151952155","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151952155?lang=en_us&edition=fundamental","pubTime":"2026-09-15 16:42","pubTimestamp":1789461741,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co.,Ltd. (SH: 600276) has announced that its subsidiary, Fujian Shengdi Pharmaceutical Co., Ltd., has received the Drug Clinical Trial Approval Notice from the...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0405327494.USD","MDTX","LU1328615791.USD","LU2289578879.USD","BK0012","BMED","BK0060","LU2580892862.HKD","LU2580892789.USD","IBBQ","LU0359201885.HKD","LU0359201612.USD","LU2097828714.EUR","LU1064131003.USD","LU1255011170.USD","LU1781817850.SGD","BK0188","LU1064130708.USD","LU1146622755.USD","LU1580142542.USD","LU2543165471.USD","BK0028","LU1969619763.USD","600276","01276","BK0196","LU1655091616.SGD","LU0359202008.SGD","LU2097828631.EUR","PSYK","BK0183","LU1997245177.USD","LU2097828557.USD","LU2488822045.USD","LU1023057109.AUD","LU2097828474.EUR","LU2495084118.USD","BK0239","IBBJ","BK1191","LU1997245094.SGD","LU0405327148.USD","LU1820825898.SGD","LU2328871848.SGD","LU1997244956.HKD","LU2097828805.USD","LU2148510915.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667109456","title":"Sino Biopharmaceutical Stock Slips 1.0% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2667109456","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667109456?lang=en_us&edition=fundamental","pubTime":"2026-09-15 16:33","pubTimestamp":1789461180,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. slipped 1.0% to 5.42 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.0% to 24667.24.Sino Biopharmaceutical Ltd. closed 38% below its 52-week high of HK$8.81, which the company achieved Sept. 16.The stock demonstrated a mixed performance when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 1.9% and Amgen Inc. remained unchanged.Trading volume totaled 59.4 million shares, compared to the 50-day average of 95.3 million shares.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YS42.EUR","BIB","IE00BJJMRZ35.SGD","LU0289739699.SGD","LU2242646821.SGD","BBH","IE00BZ08YR35.GBP","LU0058720904.USD","IE00B4R5TH58.HKD","LU2089984988.USD","LU0109394709.USD","LU1023059063.AUD","BK4585","IE0009355771.USD","BK4566","BK4534","IE00B2B36J28.USD","LU0122379950.USD","IE00BFTCPJ56.SGD","SG9999001440.SGD","LU0889565916.HKD","LU1061106388.HKD","BK1515","LU1983299246.USD","LU2112291526.USD","TBXU","HK0000165453.HKD","LU0868494617.USD","BK4139","LU1057294990.SGD","01177","IE00BZ08YT58.USD","IE00BJT1NW94.SGD","LU2468319806.SGD","BK1191","BK1521","IE0002141913.USD","BK4533","PBE","PJP","AMGN","BK4581","LU2242652126.USD","LU1571399168.USD","BK4599","BK4588","LU0320765992.SGD","IBBQ","IBB","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165786716","title":"Huangjia Ruangan Granules Receives Approval for Phase III Clinical Trial in Chronic Hepatitis B Fibrosis Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1165786716","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165786716?lang=en_us&edition=fundamental","pubTime":"2026-09-15 16:18","pubTimestamp":1789460304,"startTime":"0","endTime":"0","summary":"Zhejiang Wecome Pharmaceutical Company Limited (300878.SZ) has announced that it recently received the Drug Clinical Trial Supplemental Application Approval Notice issued by the National Medical...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDTX","BMED","IBBJ","300878","BK0239","IBBQ","PSYK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106452599","title":"Shenyang Xingqi Pharma Gains NMPA Approval to Initiate Clinical Trials for SQ-25012 Injection in Thyroid Eye Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=1106452599","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106452599?lang=en_us&edition=fundamental","pubTime":"2026-09-15 15:58","pubTimestamp":1789459095,"startTime":"0","endTime":"0","summary":"Shenyang Xingqi Pharmaceutical Co., Ltd. (300573.SZ) has announced that it recently received the \"Drug Clinical Trial Approval Notice\" issued by the National Medical Products Administration (NMPA)...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BMED","MDTX","BK0177","IBBQ","PSYK","300573","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191881847","title":"港股市场动态：海西新药股价上扬，新药申请获受理推进","url":"https://stock-news.laohu8.com/highlight/detail?id=1191881847","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191881847?lang=en_us&edition=fundamental","pubTime":"2026-09-15 14:52","pubTimestamp":1789455138,"startTime":"0","endTime":"0","summary":"港股市场上，海西新药 (02637)...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSYK","BK4585","KCAI","IBBJ","VXUS","MDTX","BK1191","BK4588","BMED","02637","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184266083","title":"Record WCLC Data From Chinese Innovators Signals Clear Recovery for CRO/CDMO Sector, Wall Street Takes Notice","url":"https://stock-news.laohu8.com/highlight/detail?id=1184266083","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184266083?lang=en_us&edition=fundamental","pubTime":"2026-09-15 07:54","pubTimestamp":1789430067,"startTime":"0","endTime":"0","summary":"The 2026 World Conference on Lung Cancer (WCLC) taking place in Seoul from September 12-15 has become a major catalyst for Chinese innovative drug developers, with a record number of clinical data...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0326950275.SGD","BK1183","BK1191","LU1008478684.HKD","01911","LU1813983027.USD","BK1161","LNGR","IBBQ","06978","LU0140636845.USD","IE00BZ08YT58.USD","LU1951186391.HKD","BK4588","CDMO","LU1226287792.SGD","LU0501845795.SGD","IE0008369823.USD","02889","BK4139","159992","BK1515","BK1539","BK1521","LU1226288170.HKD","LU0067412154.USD","02238","SG9999004220.SGD","IE00B543WZ88.USD","HK0000165453.HKD","IE0008368742.USD","LU1152091168.USD","LU1226287875.USD","LU0315179316.USD","MEDX","LU1993786604.SGD","LU0880133367.SGD","LU0314109678.HKD","LU1226287529.USD","LU1226288253.USD","LU1152091754.HKD","IE00BZ08YS42.EUR","BK1147","BK4585","IE00BZ08YR35.GBP","KCAI","BK1574","LU1807302812.USD","LU1960683339.HKD","BK1119","LU2039709279.SGD","LU0072913022.USD","KURE","VXUS","01093","BK1144","IE00B5MMRT66.SGD","LU1328277881.USD","IE00B031HY20.USD","06871"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667695453","title":"Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2667695453","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667695453?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:36","pubTimestamp":1789418160,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  rallied 1.87% to $146.41 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.48% to 7,619.98 and Dow Jones Industrial Average  falling 0.29% to 52,421.20.The stock's rise snapped a five-day losing streak.Gilead Sciences Inc. closed 6.92% below its 52-week high of $157.29, which the company achieved on February 11th.The stock outperformed some of its competitors Monday, as Johnson & Johnson  rose 0.28% to $266.32, Pfizer Inc.  remained unchanged, and Abbott Laboratories  rose 1.12% to $103.09.Trading volume  remained 1.5 million below its 50-day average volume of 6.3 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 14, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1674673428.USD","LU1066053197.SGD","IE00B19Z3581.USD","LU0861579265.USD","LU1571399168.USD","LU1674673691.USD","SG9999015952.SGD","LU1430594728.SGD","IE00B7SZLL34.SGD","MEDI","IE00BSNM7G36.USD","LU1839511570.USD","IBBQ","TMED","LU1778281490.HKD","BK4583","IE00B19Z3B42.SGD","BBH","LU2468319806.SGD","TBXU","LU1057294990.SGD","IE00BZ1G4Q59.USD","LU0965509101.SGD","LU1061106388.HKD","LU1066051498.USD","LU0320765992.SGD","IBB","LU1037948541.HKD","BK4578","LU2112291526.USD","LU0058720904.USD","SG9999015978.USD","IE00BKVL7J92.USD","BK4566","BMED","LU0965508806.USD","LU0965509283.SGD","LU1023059063.AUD","LU1585245621.USD","LU1934455194.USD","LU0114720955.EUR","BIB","LU0859254822.USD","LU0889565916.HKD","LU0882574055.USD","BK4585","LU0965509010.AUD","BK4550","LU2089984988.USD","LU0122379950.USD","BK4139","BK4568","IE00B3T34201.USD","LU0109394709.USD","LU0234570918.USD","SG9999015986.USD","LU2357627491.SGD","LU1934455277.USD","LU1037948897.HKD","LU0289739699.SGD","LU2087621335.USD","LU1934455863.HKD","BK4532","LU2324357040.USD","LU0823416689.USD","IE0002270589.USD","GILD","SG9999015945.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667695950","title":"Amgen Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2667695950","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667695950?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:35","pubTimestamp":1789418100,"startTime":"0","endTime":"0","summary":"DJ Amgen Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen Inc.  advanced 1.10% to $381.50 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.48% to 7,619.98 and Dow Jones Industrial Average  falling 0.29% to 52,421.20.The stock's rise snapped a five-day losing streak.Amgen Inc. closed 14.66% below its 52-week high of $447.03, which the company achieved on August 25th.The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson  rose 0.28% to $266.32, Pfizer Inc.  remained unchanged, and AbbVie Inc.  rose 1.81% to $261.77.Trading volume  eclipsed its 50-day average volume of 2.5 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 14, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","SG9999001440.SGD","IE0002141913.USD","BK4139","BK4585","LU2468319806.SGD","IBB","04332","LU2089984988.USD","IE00BJT1NW94.SGD","TBXU","BK4581","LU0868494617.USD","IE00BFTCPJ56.SGD","PJP","BK4566","BK4588","IE00B4R5TH58.HKD","BK4599","BBH","LU1057294990.SGD","LU2242652126.USD","LU0889565916.HKD","IBBQ","LU0109394709.USD","BK4534","IE00B2B36J28.USD","PBE","LU0320765992.SGD","LU1571399168.USD","BK4533","LU1023059063.AUD","LU2112291526.USD","LU0289739699.SGD","LU2242646821.SGD","LU1983299246.USD","LU0058720904.USD","LU0122379950.USD","LU1061106388.HKD","IE00BJJMRZ35.SGD","AMGN","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667667070","title":"Amgen’s Phase 3 Dazodalibep Study Nears Data Spotlight for Sjögren’s Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2667667070","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667667070?lang=en_us&edition=fundamental","pubTime":"2026-09-15 00:30","pubTimestamp":1789403411,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. The phase 3 study A Phase 3 Randomized, Double-blind, Placebo-controlled Stu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgens-phase-3-dazodalibep-study-nears-data-spotlight-for-sjogrens-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgens-phase-3-dazodalibep-study-nears-data-spotlight-for-sjogrens-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BIB","BK4211","LU2112291526.USD","LU1057294990.SGD","PJP","BK4588","SG9999001440.SGD","IBB","BK4533","LU0320765992.SGD","BBH","BK4534","LU1571399168.USD","LU1061106388.HKD","BK4566","LU0868494617.USD","LU1023059063.AUD","IE00BJT1NW94.SGD","BK4581","LU2242652126.USD","IE00BJJMRZ35.SGD","ISBC","IE00B2B36J28.USD","LU0289739699.SGD","BK4139","LU1983299246.USD","IE0002141913.USD","LU0058720904.USD","LU2468319806.SGD","LU2089984988.USD","TBXU","AMGN","BK4585","LU0889565916.HKD","IE0009355771.USD","LU0109394709.USD","PBE","LU0122379950.USD","IE00BFTCPJ56.SGD","BK4599","IBBQ","LU2242646821.SGD","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148029930","title":"CRO Sector Surges Strongly as Multiple Listed Companies Share Latest Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=1148029930","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148029930?lang=en_us&edition=fundamental","pubTime":"2026-09-14 22:11","pubTimestamp":1789395083,"startTime":"0","endTime":"0","summary":"Entering September, the CRO/CXO sector remains one of the most resilient directions within the pharmaceutical space, with capital attention once again intensifying around the entire chain spanning...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","ADC","BK1161","MEDX","LNGR","BK1574","NETL","BK4231","06978","BK4080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667661729","title":"Roche, GSK's Lung-Cancer Drug Candidates Show Promise in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2667661729","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667661729?lang=en_us&edition=fundamental","pubTime":"2026-09-14 22:04","pubTimestamp":1789394640,"startTime":"0","endTime":"0","summary":"1404 GMT - Roche Holding and GSK's Chinese partners reported strong clinical-trial data for their respective lung-cancer drug candidates in China-only clinical trials, analysts at J.P. Morgan write in a research note. Both drugs, one from GSK and partner Hansoh Pharmaceutical and another from Roche and MediLink, showed a 54% improvement in overall survival rates in the trials. This seems competitive relative to a 40% benefit shown by Amgen's Imdelltra in a global trial, the analysts say. Roche and MediLink's candidate tam-peli has a better tolerability profile than GSK and Hansoh's ris-rez, they add. Ris-rez has better median overall-survival data, but it will be important to confirm this result in a global trial, according to JPM. GSK shares rise 4.6% and Roche's jump 5.7%, while Hansoh's close 5.1% higher.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PJP","SG9999001440.SGD","LU0868494617.USD","LU0320765992.SGD","LU1057294990.SGD","IE00B2B36J28.USD","CANC","IBBQ","LU2242652126.USD","LU2112291526.USD","HRTS","IE0002141913.USD","TBXU","03692","RHHBY","BK1589","IBB","LU2089984988.USD","BK4566","BBH","LU1983299246.USD","LU1571399168.USD","LU0109394709.USD","PBE","LU2468319806.SGD","BK4007","IE00BJJMRZ35.SGD","BK4581","AMGN","BIB","GSK","IE00B4R5TH58.HKD","BK4599","IE00BJT1NW94.SGD","LU0122379950.USD","GSKH","LU0289739699.SGD","BK4532","LU0058720904.USD","LU1061106388.HKD","BK1191","LU1829250122.USD","03165","BK4534","LU1023059063.AUD","BK4533","LU0889565916.HKD","IE0009355771.USD","GSK.UK","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667669562","title":"FDA Approves Shorter Monitoring Time for Amgen’s Imdelltra First Two Doses","url":"https://stock-news.laohu8.com/highlight/detail?id=2667669562","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667669562?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:06","pubTimestamp":1789391173,"startTime":"0","endTime":"0","summary":"FDA approves shorter monitoring time for Amgen’s Imdelltra first two dosesFDA cleared a label update for Amgen’s IMDELLTRA that cuts post-infusion monitoring for the first two doses to 6-8 hours.Prior","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nNDLtJX3g:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","LU0109394709.USD","LU0058720904.USD","LU2242652126.USD","SG9999001440.SGD","PJP","IBB","BK4566","LU2112291526.USD","BK4139","LU2242646821.SGD","BK4599","LU1023059063.AUD","BK4533","LU0320765992.SGD","LU1983299246.USD","PBE","LU0889565916.HKD","BIB","TBXU","LU0289739699.SGD","LU1061106388.HKD","BK4534","AMGN","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","BK4585","LU2468319806.SGD","IBBQ","BBH","BK4588","IE0009355771.USD","LU0868494617.USD","LU1571399168.USD","IE00BJT1NW94.SGD","LU0122379950.USD","BK4581","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU1057294990.SGD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667778666","title":"Amgen - Imdelltra Monitoring Reduced to 6-8 Hours for First Two Infusions","url":"https://stock-news.laohu8.com/highlight/detail?id=2667778666","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667778666?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:00","pubTimestamp":1789390805,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUA41PDLW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1023059063.AUD","LU2242652126.USD","PJP","BK4533","LU1061106388.HKD","BK4139","LU0289739699.SGD","LU0122379950.USD","TBXU","SG9999001440.SGD","AMGN","BK4588","IE00BJJMRZ35.SGD","LU0058720904.USD","IE0009355771.USD","BK4534","LU1571399168.USD","PBE","IE00B4R5TH58.HKD","IE00B2B36J28.USD","IBB","LU0889565916.HKD","BK4581","LU2112291526.USD","IE00BJT1NW94.SGD","LU1057294990.SGD","BK4566","BK4585","BIB","LU0109394709.USD","IBBQ","BK4599","BBH","LU2468319806.SGD","LU2089984988.USD","IE0002141913.USD","LU0868494617.USD","LU1983299246.USD","IE00BFTCPJ56.SGD","LU0320765992.SGD","LU2242646821.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}